BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23636159)

  • 1. Advocating zoster vaccination in a community pharmacy through use of personal selling.
    Bryan AR; Liu Y; Kuehl PG
    J Am Pharm Assoc (2003); 2013; 53(1):70-7. PubMed ID: 23636159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies.
    Wang J; Ford LJ; Wingate L; Uroza SF; Jaber N; Smith CT; Randolph R; Lane S; Foster SL
    J Am Pharm Assoc (2003); 2013; 53(1):46-53. PubMed ID: 23636155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.
    Teeter BS; Garza KB; Stevenson TL; Williamson MA; Zeek ML; Westrick SC
    Vaccine; 2014 Sep; 32(43):5749-54. PubMed ID: 25171848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using motivational interviewing in the community pharmacy to increase adult immunization readiness: A pilot evaluation.
    Brackett A; Butler M; Chapman L
    J Am Pharm Assoc (2003); 2015; 55(2):182-6. PubMed ID: 25615903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Pharmacist Interventions on Herpes Zoster Vaccination Rates.
    Eid DD; Meagher RC; Lengel AJ
    Consult Pharm; 2015 Aug; 30(8):459-62. PubMed ID: 26260642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of targeted automated messages on herpes zoster immunization numbers in an independent community pharmacy.
    Bedwick BW; Garofoli GK; Elswick BM
    J Am Pharm Assoc (2003); 2017; 57(3S):S293-S297.e1. PubMed ID: 28408168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective.
    Wood HM; McDonough RP; Doucette WR
    J Am Pharm Assoc (2003); 2009; 49(1):12-7. PubMed ID: 19196591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a vaccine screening program at an independent community pharmacy.
    Rhodes LA; Branham AR; Dalton EE; Moose JS; Marciniak MW
    J Am Pharm Assoc (2003); 2017; 57(2):222-228. PubMed ID: 27964886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic analysis of a herpes zoster vaccination program in 19 affiliated supermarket pharmacies.
    Hedden MA; Kuehl PG; Liu Y
    J Am Pharm Assoc (2003); 2014; 54(4):390-6. PubMed ID: 24952742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving herpes zoster vaccination rates through use of a clinical pharmacist and a personal health record.
    Otsuka SH; Tayal NH; Porter K; Embi PJ; Beatty SJ
    Am J Med; 2013 Sep; 126(9):832.e1-6. PubMed ID: 23830534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving pneumococcal and herpes zoster vaccination uptake: expanding pharmacist privileges.
    Taitel MS; Fensterheim LE; Cannon AE; Cohen ES
    Am J Manag Care; 2013 Sep; 19(9):e309-13. PubMed ID: 24449960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The essential role of pharmacists facilitating vaccination in older adults: the case of Herpes Zoster.
    Tak CR; Marciniak MW; Savage A; Ozawa S
    Hum Vaccin Immunother; 2020; 16(1):70-75. PubMed ID: 31369322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of an immunization platform in community pharmacies.
    Wang AB; Bacci JL; Amoo M; Ree C; Firebaugh R; Odegard P
    J Am Pharm Assoc (2003); 2019; 59(4S):S151-S155. PubMed ID: 31255521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two training methods in community pharmacy: Project VACCINATE.
    Lin JL; Bacci JL; Reynolds MJ; Li Y; Firebaugh RG; Odegard PS
    J Am Pharm Assoc (2003); 2018; 58(4S):S94-S100.e3. PubMed ID: 29753630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assessment of Polish pharmacy staff's readiness to promote health.
    Bojar I; Sarecka-Hujar B; Owoc J; Pawełczak-Barszczowska A; Raczkiewicz D
    Int J Clin Pharm; 2020 Oct; 42(5):1354-1363. PubMed ID: 32772305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric asthma medication therapy management through community pharmacy and primary care collaboration.
    Bradley CL; Luder HR; Beck AF; Bowen R; Heaton PC; Kahn RS; Mansour M; Obszarski S; Frede SM
    J Am Pharm Assoc (2003); 2016; 56(4):455-60. PubMed ID: 27245855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of passive and active promotional strategies on patient acceptance of medication therapy management services.
    Huet AL; Frail CK; Lake LM; Snyder ME
    J Am Pharm Assoc (2003); 2015; 55(2):178-81. PubMed ID: 25658223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled study of practice facilitation to improve the provision of medication management services in Alberta community pharmacies.
    Houle SK; Charrois TL; Faruquee CF; Tsuyuki RT; Rosenthal MM
    Res Social Adm Pharm; 2017; 13(2):339-348. PubMed ID: 27017157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.